Amarin Corp Plc (AMRN)

[Invest83838]

BCBS is infringing on Amarin Vascepa patents for CVD

with their dropping of coverage of Vascepa

which will pretty much "seal the deal"

for most all High Trig & CVD prescriptions going to Generics

If Amarin doesn't go after BCBS,

They will prove again to be worthless